The most promising use of HLA-DR expression as a marker on CD14+ cells is its association with infection after non-infectious insults such as surgery [14], liver transplantation [15], trauma [16], pancreatitis [17], or burn injury [18]. This evidence concerns the gene CD14 and pancreatitis.